Antibiotic CAS 73384-59-5 Ceftriaxone Sodium Ceftriaxone Powder

• Customization: Available
• CAS No.: 73384-59-5
• Formula: C18h18n8o7s3
• Model NO.: QS-Ceftriaxone
• EINECS: 277-930-0; 277-405-6
• Packaging Material: Negotiable
• Storage Method: Normal
• Shelf Life: >12 Months
• Nutrient Composition: Negotiable
• Resource: Ceftriaxone
• The content of active substances: >99%
• Product Name: Ceftriaxone
• Name: Ceftriaxone Powder
• Appearance: White Powder
• Colour: White
• Grade: Veterinary Grade
• Assay: >99%
• Application: Veterinary
• Specific: COA
• Test Method: HPLC
• Melting Point: 155c
• Density: 1.96
• MW: 554.58000
• Storage Temperature: 2-8c
• Refractive Index: 1.889
• Mf: C18h18n8o7s3
• Transport Package: Negotiable
• Specification: >99%
• Trademark: QS-Ceftriaxone
• Origin: Xi`an
• Production Capacity: 1000kg/Month

Product Description

Antibiotic CAS 73384-59-5 Ceftriaxone Sodium Ceftriaxone Powder

Product Description

Product Details

Product Name	Ceftriaxone
Appearance	White Powder
Assay	>99%
MW	554.58000
MF	C18H18N8O7S3
Density	1.96
Melting Point	155c

Ceftriaxone sodium exhibits a broad antibacterial spectrum comparable to cefotaxime sodium. It demonstrates strong efficacy against pathogens such as E.coli ,Klebsiella pneumoniae, indole-positive Proteus, Haemophilus influenzae,Serratia marcescens,Neisseria meningitidis, and Neisseria gonorrhoeae. Additionally, it shows moderate activity against Streptococcus pneumoniae, Streptococcus species, and Staphylococcus aureus. However, its effectiveness is limited against Pseudomonas aeruginosa and Enterococcus species. Notably, methicillin-resistant  Staphylococcus aureus (MRSA) and most strains of Bacteroides fragilis are resistant to ceftriaxone. This antibiotic is widely used for treating severe infections due to its broad coverage and potent antibacterial action, particularly against Gram-negative and some Gram-positive bacteria.

Application&Function

Ceftriaxone Sodium is an antibiotic effective for treating a variety of bacterial infections. As a third-generation cephalosporin, it demonstrates significant efficacy in the following infections:  
1.Ear infections:Such as otitis media caused by Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pyogenes.  
2.Nasal sinus and throat infections:Such as sinusitis, tonsillitis, and pharyngitis caused by Streptococcus pyogenes.  
3.Chest and lung infections: Such as bronchitis and pneumonia caused by Streptococcus pneumoniae and Haemophilus influenzae.  
4.Urinary tract infections and uncomplicated gonorrhea:Such as infections caused by Neisseria gonorrhoeae.  
Ceftriaxone Sodium is primarily used to treat infections caused by susceptible strains, including meningitis, pneumonia, skin and soft tissue infections, peritonitis, urinary tract infections, gonorrhea, liver and gallbladder infections, surgical trauma, sepsis, and genital infections. It is one of the first-line drugs for treating gonorrhea. Additionally, Ceftriaxone injection is often used in combination (but not direct mixing) with macrolide and/or aminoglycoside antibiotics to treat community-acquired or mild to moderate healthcare-associated pneumonia. It is also a commonly used drug for treating bacterial meningitis.

Specification